Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation

Journal of Virology

Volumn 83, Issue 17, 2009, Pages 8869-8884

  Seckert, Christof K ^a   Renzaho, Angélique ^a   Tervo, Hanna Mari ^a   Krause, Claudia ^a   Deegen, Petra ^a   Kühnapfel, Birgit ^a   Reddehase, Matthias J ^a   Grzimek, Natascha K A ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL TYPE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; EXPLANT; FEMALE; GENE EXPRESSION; LIVER CELL; LIVER SINUSOID; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX CHROMOSOME; SRY GENE; TISSUE CULTURE; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS REACTIVATION; Y CHROMOSOME; ANIMAL; BAGG ALBINO MOUSE; BETAHERPESVIRINAE; GENE EXPRESSION PROFILING; LIVER; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

CYTOMEGALOVIRUS; MURID HERPESVIRUS 1; MURINAE;

ANIMALS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENES, VIRAL; LIVER; MALE; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 69249231020     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00870-09     Document Type: Article

References (116)

1. Agresti, A. 1992. A survey of exact inference for contingency tables. Stat. Sci. 7:131-177.
2. Alterio de Goss, M., R. Holtappels, H.-P. Steffens, J. Podlech, P. Angele, L. Dreher, D. Thomas, and M. J. Reddehase. 1998. Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigenpresenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells. J. Virol. 72:7733-7744.
3. Ambion. 2009. MEGAscript™ high yield transcription kit instruction manual (manual version 0209). Ambion, Austin, TX.
4. Angulo, A., P. Ghazal, and M. Messerle. 2000. The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J. Virol. 74:11129-11136.
5. Asahara, T., H. Masuda, T. Takahashi, C. Kalka, C. Pastore, M. Silver, M. Kearne, M. Magner, and J. M. Isner. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85:221-228.
6. Baba, S., H. Fujii, T. Hirose, K. Yasuchika, H. Azuma, T. Hoppo, M. Naito, T. Machimoto, and I. Ikai. 2004. Commitment of bone marrow cells to hepatic stellate cells in mouse. J. Hepatol. 40:255-260. (Pubitemid 38115830)
7. Bain, M., M. Reeves, and J. Sinclair. 2006. Regulation of human cytomegalovirus gene expression by chromatin remodeling, p. 167-183. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, Norfolk, United Kingdom.
8. Balthesen, M., L. Dreher, P. Lucëin, and M. J. Reddehase. 1994. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J. Gen. Virol. 75:2329-2336.
9. Balthesen, M., M. Messerle, and M. J. Reddehase. 1993. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:5360-5366. (Pubitemid 23241369)
10. Benten, D., A. Follenzi, K. K. Bhargava, V. Kumaran, C. J. Palestro, and S. Gupta. 2005. Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice. Hepatology 42:140-148. (Pubitemid 40911321)
11. Bevan, I. S., C. C. Sammons, and C. Sweet. 1996. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction. J. Med. Virol. 48:308-320.
12. Blomhoff, R., C. A. Drevon, W. Eskild, P. Helgerud, K. R. Norum, and T. Berg. 1984. Clearance of acetyl low density lipoprotein by rat liver endothelial cells. J. Biol. Chem. 259:8898-8903.
13. Blouin, A., R. P. Bolender, and E. R. Weibel. 1977. Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J. Cell Biol. 72:441-455.
14. + cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93:394-398.
15. Braet, F., and E. Wisse. 2002. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp. Hepatol. 1:1-17.
16. Breiner, K. M., H. Schaller, and P. A. Knolle. 2001. Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver targeting of hepatotropic microorganisms. Hepatology 34:803-808.
17. Bühler, B., G. M. Keil, F. Weiland, and U. H. Koszinowski. 1990. Characterization of the murine cytomegalovirus early transcription unit e1 that is induced by immediate-early proteins. J. Virol. 64:1907-1919.
18. Busche, A., A. Marquardt, A. Bleich, P. Ghazal, A. Angulo, and M. Messerle. 2009. The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs. J. Virol. 83:4030-4038.
19. Chee, M., S. A. Rudolph, B. Plachter, B. Barrell, and G. Jahn. 1989. Identification of the major capsid protein gene of human cytomegalovirus. J. Virol. 63:1345-1353. (Pubitemid 19061376)
20. Cheung, K.-S., and D. J. Lang. 1977. Detection of latent cytomegalovirus in murine salivary and prostate explant cultures and cells. Infect. Immun. 15:568-575.
21. Chi, J.-T., H. Y. Chang, G. Haraldsen, F. L. Jahnsen, O. G. Troyanskaya, D. S. Chang, Z. Wang, S. G. Rockson, M. van de Rijn, D. Botstein, and P. O. Brown. 2003. Endothelial cell diversity revealed by global expression pro- filing. Proc. Natl. Acad. Sci. USA 100:10623-10628.
22. Choi, K., M. Kennedy, A. Kazarov, J. C. Papadimitriou, and G. Keller. 1998. A common precursor for hematopoietic and endothelial cells. Development 125:725-732. (Pubitemid 28108096)
23. Cicin-Sain, L., J. Podlech, M. Messerle, M. J. Reddehase, and U. H. Koszinowski. 2005. Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J. Virol. 79:9492-9502. (Pubitemid 41022293)
24. Ciocco-Schmitt, G. M., Z. Karabekian, E. W. Godfrey, R. M. Stenberg, A. E. Campbell, and J. A. Kerry. 2002. Identification and characterization of novel murine cytomegalovirus M112-113 (e1) gene products. Virology 294:199-208.
25. Collins, T., C. Pomeroy, and M. C. Jordan. 1993. Detection of latent cytomegalovirus DNA in diverse organs of mice. J. Infect. Dis. 168:725-729.
26. Constien, R., A. Forde, B. Liliensiek, H. J. Grone, P. Nawroth, G. Hammerling, and B. Arnold. 2001. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 30:36-44.
27. Conway, E. M., and P. Carmeliet. 2004. The diversity of endothelial cells: a challenge for therapeutic angiogenesis. Genome Biol. 5:207.
28. Cormier, E. G., R. J. Durso, F. Tsamis, L. Boussemart, C. Manix, W. C. Olson, J. P. Gardner, and T. Dragic. 2004. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc. Natl. Acad. Sci. USA 101:14067-14072.
29. Crispe, I. N. 2003. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3:51-62.
30. Crosby, J. R., W. E. Kaminski, G. Schatteman, P. J. Martin, E. W. Raines, R. A. Seifert, and D. F. Bowen-Pope. 2000. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ. Res. 87:728-730.
31. Daoust, R., and A. Cantero. 1959. The numerical proportions of cell types in rat liver during carcinogenesis by 4-dimethylaminoazobenzene (DAB). Cancer Res. 19:757-762.
32. DeLisser, H. M., P. J. Newman, and S. M. Albelda. 1994. Molecular and functional aspects of PECAM-1/CD31. Immunol. Today 15:490-495.
33. Elvevold, K., B. Smedsrod, and I. Martinez. 2008. The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity. Am. J. Physiol. Gastrointest. Liver Physiol. 294:G391-G400.
34. Emery, V. C. 1998. Relative importance of cytomegalovirus load as a risk factor for cytomegalovirus disease in the immunocompromised host. Monogr. Virol. 21:288-301.
35. Fazekas de St. Groth, S. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods 49:R11-R23.
36. Fujii, H., T. Hirose, S. Oe, K. Yasuchika, H. Azuma, T. Fujikawa, M. Nagao, and Y. Yamaoka. 2002. Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J. Hepatol. 36:653-659. (Pubitemid 34499403)
37. Gao, Z., V. C. McAlister, and G. M. Williams. 2001. Repopulation of liver endothelium by bone-marrow-derived cells. Lancet 357:932-933. (Pubitemid 32247285)
38. Geijtenbeek, T. B. H., P. C. Groot, M. A. Nolte, S. J. van Vliet, S. T. Gangaram-Panday, G. C. F. van Duijnhoven, G. Kraal, A. J. M. van Oosterhout, and Y. van Kooyk. 2002. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 100:2908-2916.
39. Göttlicher, M., S. Minucci, P. Zhu, O. H. Krämer, A. Schimpf, S. Giavara, J. P. Sleeman, F. L. Coco, C. Nervi, P. G. Pelicci, and T. Heinzel. 2001. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20:6969-6978.
40. Grzimek, N. K. A., D. Dreis, S. Schmalz, and M. J. Reddehase. 2001. Random, asynchronous, and asymmetric transcriptional activity of enhancer- flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J. Virol. 75:2692-2705.
41. Grzimek, N. K. A., J. Podlech, H.-P. Steffens, R. Holtappels, S. Schmalz, and M. J. Reddehase. 1999. In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoterenhancer of human cytomegalovirus. J. Virol. 73:5043-5055.
42. Gubbay, J., J. Collignon, P. Koopman, B. Capel, A. Economou, A. Münsterberg, N. Vivian, P. Goodfellow, and R. Lovell-Badge. 1990. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 346:245-250.
43. Gunsilius, E., H. C. Duba, A. L. Petzer, C. M. Kähler, K. Grünewald, G. Stockhammer, C. Gabl, S. Dirnhofer, J. Clausen, and G. Gastl. 2000. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355:1688-1691.
44. Hamilton, J. D., and B. J. Seaworth. 1985. Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model. Transplantation 39:290-296.
45. Holtappels, R., M. W. Munks, J. Podlech, and M. J. Reddehase. 2006. CD8 T-cell-based immunotherapy of cytomegalovirus disease in the mouse model of the immunocompromised bone marrow transplantation recipient, p. 383-418. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, Norfolk, United Kingdom.
46. Holtappels, R., J. Podlech, G. Geginat, H.-P. Steffens, D. Thomas, and M. J. Reddehase. 1998. Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J. Virol. 72:7201-7212. (Pubitemid 28377849)
47. Hummel, M., and M. M. Abecassis. 2002. A model for reactivation of CMV from latency. J. Clin. Virol. 25:S123-S136.
48. Jarvis, M. A., and J. A. Nelson. 2007. Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J. Virol. 81:2095-2101.
49. Jordan, M. C., and V. L. Mar. 1982. Spontaneous activation of latent cytomegalovirus from murine spleen explants: role of lymphocytes and macrophages in release and replication of virus. J. Clin. Investig. 70:762-768.
50. Katz, S. C., V. G. Pillarisetty, J. I. Bleier, A. B. Shah, and R. P. DeMatteo. 2004. Liver sinusoidal endothelial cells are insufficient to activate T cells. J. Immunol. 173:230-235.
51. Keil, G. M., A. Ebeling-Keil, and U. H. Koszinowski. 1987. Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products. J. Virol. 61:526-533.
52. Keil, G. M., A. Ebeling-Keil, and U. H. Koszinowski. 1987. Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J. Virol. 61:1901-1908.
53. Klotman, M. E., S. C. Henry, R. C. Greene, P. C. Brazy, P. E. Klotman, and J. D. Hamilton. 1990. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. J. Infect. Dis. 161:220-225.
54. Klotman, M. E., D. Starnes, and J. D. Hamilton. 1985. The source of murine cytomegalovirus in mice receiving kidney allografts. J. Infect. Dis. 152:1192-1196.
55. Kmieć, Z. 2001. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 161:1-151.
56. Knolle, P. A., and G. Gerken. 2000. Local control of the immune response in the liver. Immunol. Rev. 174:21-34.
57. Knolle, P. A., and A. Limmer. 2003. Control of immune responses by scavenger liver endothelial cells. Swiss Med. Wkly. 133:501-506.
58. Knook, D. L., and E. C. Sleyster. 1976. Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp. Cell Res. 99:444-4449.
59. Koffron, A. J., M. Hummel, B. K. Patterson, S. Yan, D. B. Kaufmann, J. P. Fryer, F. P. Stuart, and M. I. Abecassis. 1998. Cellular localization of latent murine cytomegalovirus. J. Virol. 72:95-103.
60. Koopman, P., A. Munsterberg, B. Capel, N. Vivian, and R. Lovell-Badge. 1990. Expression of a candidate sex-determining gene during mouse testis differentiation. Nature 348:450-452. (Pubitemid 120015087)
61. Kruh, J. 1982. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem. 42:65-82.
62. Kurz, S. K., M. Rapp, H.-P. Steffens, N. K. A. Grzimek, S. Schmalz, and M. J. Reddehase. 1999. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol. 73:482-494.
63. Kurz, S. K., and M. J. Reddehase. 1999. Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J. Virol. 73:8612-8622.
64. Kurz, S. K., H.-P. Steffens, A. Mayer, J. R. Harris, and M. J. Reddehase. 1997. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:2980-2987.
65. Lautenschlager, I., L. Halme, K. Höckerstedt, L. Krogerus, and E. Taskinen. 2006. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations. Transpl. Infect. Dis. 8:21-30.
66. Lefkovits, I., and H. Waldman. 1979. Limiting dilution analysis of cells in the immune system, p. 38-82. Cambridge University Press, Cambridge, England.
67. Limmer, A., and P. A. Knolle. 2001. Liver sinusoidal endothelial cells: a new type of organ-resident antigen-presenting cell. Arch. Immunol. Ther. Exp. 49:S7-S11.
68. + T cells results in antigen-specific T-cell tolerance. Nat. Med. 6:1348-1354.
69. Lohse, A. W., P. A. Knolle, K. Bilo, A. Uhrig, C. Waldmann, M. Ibe, E. Schmitt, G. Gerken, and K.-H. Meyer Zum Büschenfelde. 1996. Antigenpresenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 110:1175-1181.
70. Luna, G., J. Paez, and J. E. Cardier. 2004. Expression of the hematopoietic stem cell antigen Sca-1 (LY-6A/E) in liver sinusoidal endothelial cells: possible function of Sca-1 in endothelial cells. Stem Cells Dev. 13:528-535. (Pubitemid 39473583)
71. Mangin, M., K. Ikeda, and A. E. Broadus. 1990. Structure of the mouse gene encoding parathyroid hormone-related peptide. Gene 95:195-202.
72. Mayer, A., J. Podlech, S. Kurz, H.-P. Steffens, S. Maiberger, K. Thalmeier, P. Angele, L. Dreher, and M. J. Reddehase. 1997. Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J. Virol. 71:4589-4598. (Pubitemid 27204152)
73. Mercer, J. A., C. A. Wiley, and D. H. Spector. 1988. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J. Virol. 62:987-997.
74. Messerle, M., B. Bühler, G. M. Keil, and U. H. Koszinowski. 1992. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J. Virol. 66:27-36.
75. Mocarski, E. S., Jr., G. Hahn, K. L. White, J. Xu, B. Slobedman, L. Hertel, S. A. Aguirre, and S. Noda. 2006. Myeloid cell recruitment and function in pathogenesis and latency, p. 465-481. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, Norfolk, United Kingdom.
76. Mutimer, D. 1996. CMV infection of transplant recipients. J. Hepatol. 25:259-269.
77. Nagelkerke, J. F., K. P. Barto, and T. J. C. van Berkel. 1983. In vivo and in vitro uptake and degradation of acetyl low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J. Biol. Chem. 258:12221-12227.
78. Newman, P. J. 1994. The role of PECAM-1 in vascular cell biology. Ann. N. Y. Acad. Sci. 714:165-174.
79. Onoe, T., H. Ohdan, D. Tokita, M. Shishida, Y. Tanaka, H. Hara, W. Zhou, K. Ishiyama, H. Mitsuta, K. Ide, and T. Asahara. 2005. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice. J. Immunol. 175:139-146. (Pubitemid 40884310)
80. Ortega, N., H. Hutchings, and J. Plouet. 1999. Signal relays in the VEGF system. Front. Biosci. 4:D141-D152.
81. Pampou, S. Y., S. N. Gnedoy, V. B. Bystevskaya, V. N. Smirnov, E. I. Chazov, J. L. Melnick, and M. E. DeBakey. 2000. Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta. Virchows Arch. 436:539-552.
82. Pitas, R. E., J. Boyles, R. W. Mahley, and D. M. Bissell. 1985. Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells. J. Cell Biol. 100:103-117. (Pubitemid 15151886)
83. Podlech, J., R. Holtappels, N. K. A. Grzimek, and M. J. Reddehase. 2002. Animal models: murine cytomegalovirus. Methods Microbiol. 32:493-525.
84. Podlech, J., R. Holtappels, N. Wirtz, H.-P. Steffens, and M. J. Reddehase. 1998. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J. Gen. Virol. 79:2099-2104.
85. Pollock, J. L., R. M. Presti, S. Paetzold, and H. W. Virgin IV. 1997. Latent murine cytomegalovirus infection in macrophages. Virology 227:168-179. (Pubitemid 27241066)
86. Pomeroy, C., P. J. Hilleren, and M. C. Jordan. 1991. Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J. Virol. 65:3330-3334.
87. Qiagen. 2006. DNeasy blood and tissue handbook (manual no. 07/2006). Qiagen, Hilden, Germany.
88. Qiagen. 2006. RNeasy mini handbook (manual no. 04/2006). Qiagen, Hilden, Germany.
89. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849. (Pubitemid 26378467)
90. Reddehase, M. J. 2006. Preface, p. XXIII-XXVII. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, Norfolk, United Kingdom.
91. Reddehase, M. J., M. Balthesen, M. Rapp, S. Jonjić, I. Pavić, and U. H. Koszinowski. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:185-193.
92. Reddehase, M. J., J. Podlech, and N. K. A. Grzimek. 2002. Mouse models of cytomegalovirus latency: overview. J. Clin. Virol. 25:S23-S36.
93. Reddehase, M. J., C. O. Simon, C. K. Seckert, N. Lemmermann, and N. K. A. Grzimek. 2008. Murine model of cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325:315-332.
94. Reeves, M., and J. Sinclair. 2008. Aspects of human cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325:297-313.
95. Reeves, M. B., H. Coleman, J. Chadderton, M. Goddart, J. G. P. Sissons, and J. H. Sinclair. 2004. Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo. J. Gen. Virol. 85:3337-3341.
96. Roizman, B., and A. E. Sears. 1987. An inquiry into the mechanisms of herpes simplex virus latency. Annu. Rev. Microbiol. 41:543-571.
97. Sacher, T., J. Podlech, C. A. Mohr, S. Jordan, Z. Ruzsics, M. J. Reddehase, and U. H. Koszinowski. 2008. The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 3:263-272.
98. Schrage, A., C. Loddenkemper, U. Erben, U. Lauer, G. Hausdorf, P. R. Jungblut, J. Johnson, P. A. Knolle, M. Zeitz, A. Hamman, and K. Klugewitz. 2008. Murine CD146 is widely expressed on endothelial cells and is recognized by the monoclonal antibody ME-9F1. Histochem. Cell Biol. 129:441-451.
99. Seckert, C. K., A. Renzaho, M. J. Reddehase, and N. K. Grzimek. 2008. Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection. Med. Microbiol. Immunol. 197:251-259.
100. Simon, C. O., R. Holtappels, H.-M. Tervo, V. Böhm, T. Däubner, S. A. Oehrlein-Karpi, B. Kühnapfel, A. Renzaho, D. Strand, J. Podlech, M. J. Reddehase, and N. K. A. Grzimek. 2006. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J. Virol. 80:10436-10456.
101. Simon, C. O., C. K. Seckert, D. Dreis, M. J. Reddehase, and N. K. Grzimek. 2005. Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J. Virol. 79:326-340.
102. Slobedman, B., and E. S. Mocarski. 1999. Quantitative analysis of latent human cytomegalovirus. J. Virol. 73:4806-4812. (Pubitemid 29246740)
103. Smedsrød, B. 2004. Clearance function of scavenger endothelial cells. Comp. Hepatol. 3(Suppl. 1):S22.
104. Starzl, T. E. 2001. The "privileged" liver and hepatic tolerogenicity. Liver Transpl. 7:918-920.
105. Steffens, H.-P., J. Podlech, S. Kurz, P. Angele, D. Dreis, and M. J. Reddehase. 1998. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J. Virol. 72:5006-5015.
106. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106-109. (Pubitemid 24253184)
107. Streblow, D. N., S. M. Varnum, R. D. Smith, and J. A. Nelson. 2006. A proteomics analysis of human cytomegalovirus particles, p. 91-110. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, Norfolk, United Kingdom.
108. Takakura, N., T. Watanabe, S. Suenobu, Y. Yamada, T. Noda, Y. Ito, M. Satake, and T. Suda. 2000. A role for hematopoietic stem cells in promoting angiogenesis. Cell 102:199-209.
109. Tuma, P. L., and A. L. Hubbard. 2003. Transcytosis: crossing cellular barriers. Physiol. Rev. 83:871-932.
110. Uitenbroek, D. G. 1997. Binominal. SISA. http://www.quantitativeskills. com /sisa/. Accessed 30 June 2009.
111. Wagner, M., S. Jonjic, U. H. Koszinowski, and M. Messerle. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060. (Pubitemid 29327894)
112. Weibel, E. R., W. Stäubli, H. R. Gnägi, and F. A. Hess. 1969. Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J. Cell Biol. 42:68-91.
113. Wilhelmi, V., C. O. Simon, V. Böhm, T. Däubner, S. Emde, D. Strand, A. Renzaho, N. A. Lemmermann, C. K. Seckert, M. J. Reddehase, and N. K. Grzimek. 2008. Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissues. J. Virol. 82:9900-9916.
114. Wilson, E. J., D. N. Medearis, L. V. Barrett, and R. H. Rubin. 1985. Activation of latent murine cytomegalovirus in cardiac explant and cell cultures. J. Infect. Dis. 152:625-626.
115. Yoshida, M., K. Masako, M. Aktia, and T. Beppu. 1990. Potent and specific inhibitor of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 28:17174-17179.
116. Zhou, W., M. Inada, T.-P. Lee, D. Benten S. Lyubsky, E. E. Bouhassira, S. Gupta, and H.-M. Tsai. 2005. ADAMTS13 is expressed in hepatic stellate cells. Lab. Investig. 85:780-788.